Table 1 Baseline characteristics and clinical outcomes of patients undergoing LCBDE + PC + self-disengaging biliary stent drainage, with comparison between bile leakage and Non-Bile leakage Groups.
Variables | Overall (n = 343) | No bile leakage (n = 318) | Bile leakage (n = 25) | P value |
|---|---|---|---|---|
Age (years) | 62.6 ± 14.8 | 62.3 ± 14.9 | 66.0 ± 13.7 | 0.233 |
Female, n (%) | 165 (48.1) | 155 (48.7) | 10 (40.0) | 0.400 |
CCI score | 2 (1–4) | 2 (1, 3) | 4 (3, 5) | < 0.001 |
BMI (m/kg2) | 24.2 ± 3.3 | 24.2 ± 3.3 | 24.2 ± 3.5 | 0.965 |
Diameter of CBD (mm) | 10 (8, 12) | 10 (8, 12) | 10 (8, 11) | 0.483 |
Biliary Dilatation (> 8 mm), n (%) | 225 (65.6) | 209 (65.7) | 16 (64) | 0.861 |
Diameter 7–8 mm, n (%) | 93 (27.1) | 86 (27.1) | 7 (28) | |
Diameter 5–6 mm, n (%) | 25 (7.3) | 23 (7.2) | 2 (8) | |
Obstructive jaundice, n (%) | 151 (44.0) | 137 (43.1) | 14 (56) | 0.210 |
Acute cholangitis, n (%) | 71 (20.7) | 62 (19.5) | 9 (36) | 0.050 |
Preoperative hypoproteinemia, n (%) | 81 (23.7) | 75 (23.6) | 6 (24) | 0.962 |
History of abdominal surgery, n (%) | 53 (15.5) | 49 (15.4) | 4 (16) | 1.000 |
ASA class, n (%) | 0.532 | |||
I | 14 (4.1) | 14 (4.4) | 0 | |
II | 225 (65.6) | 210 (66.0) | 15 (60.0) | |
III | 103 (30.0) | 93 (29.2) | 10 (40.0) | |
IV | 1 (0.3) | 1 (0.3) | 0 | |
Operative time (min) | 85 (70, 110) | 86 (70, 110) | 80 (70, 120) | 0.815 |
Operative blood loss (mL) | 20 (15, 20) | 20 (15, 20) | 20 (20, 20) | 0.871 |
Postoperative hospital stay (days) | 8 (8, 10) | 8 (8, 9) | 10 (9, 15) | < 0.001 |
Hospitalization costs (CNY) | 28,143 (25522, 32809) | 27,834 (25351, 32192) | 32,010 (27780, 39123) | 0.003 |
Other major associated complication, n (%) | – | 7 (2.2) | 4 (16.0) | 0.005 |
Biliary stricture, n (%) | 1 (0.3) | 0 | 1 (4.0) | 0.073 |
Recurrent stones, n (%) | 2 (0.6) | 2 (0.6) | 0 | 1.000 |
Pneumonia, n (%) | 7 (2) | 4 (1.3) | 3 (12.0) | 0.010 |
30-day mortality, n (%) | 1 (0.3) | 1 (0.3) | 0 | 1.000 |
